NCT07030465Completed
Therapeutic Effects of Press Needle on 5-D Pruritus Scale in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
Comparison of the Therapeutic Effects of Press Needle and Sham Press Needle on 5-D Pruritus Scale in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
The goal of this clinical trial is to assess whether press needle acupuncture (PN) is more effective than sham press needle (sham PN) in reducing pruritus in patients with chronic kidney disease-associated pruritus (CKDaP) undergoing hemodialysis. The main questions it aims to answer are: * Does PN, compared to sham PN, reduce pruritus severity as measured by 5-D Pruritus Scale after the 2nd, 4th, 6th, and 8th therapy sessions? * Does PN, compared to sham PN, maintain a superior reduction in pruritus severity four weeks after the final session? * Are there any side effects associated with PN or sham PN in CKDaP patients on hemodialysis? Participants will: * Be patients undergoing hemodialysis with confirmed CKDaP * Undergo cognitive screening with MMSE to ensure accurate self-reporting * Be randomly assigned to receive either PN (needle inserted) or sham PN (tape only) * Have PN or sham PN applied unilaterally to acupoints LI11, SP10, ST36, and SP6, replaced every 3-4 days over a 4-week period * Complete the 5-D Pruritus Scale questionnaire before intervention, after every 2 sessions (2nd, 4th, 6th, 8th), and 4 weeks post-treatment
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 12 Jun 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 13 Oct 2025
- Lead sponsor
- Universitas Indonesia
- Diseases
- Chronic kidney disease
- NCT number
- NCT07030465
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 1 Aug 2025 to the primary completion date, 13 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects have a history of hypersensitivity reactions to previous acupuncture therapy (such as metal allergy, atopy, keloids, or other hypersensitivities).
Other illness
- Subjects have malignancies or infectious lesions at the acupuncture points to be treated.
- Subjects have primary skin diseases such as allergic dermatitis, irritant contact dermatitis, neurodermatitis, or psoriasis.
Who the study is looking for
- Patients with CKD-associated pruritus (CKDaP) undergoing regular hemodialysis twice a week for at least 6 months and in a hemodynamically stable condition, who meet the criteria for moderate to severe pruritus based on the 5-D Pruritus Scale
- Subjects aged between 18 and 65 years.
- Subjects have not received acupuncture therapy for at least one month prior to the study.
- Subjects have good cognitive function as assessed by the MMSE.
- Subjects are willing to participate in the study according to the scheduled timeline and have signed the informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitas Indonesia Coordinator of this site? Confirm its status | Jakarta Pusat | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.